Literature DB >> 12766002

Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease.

Thomas Mueller1, Alfons Gegenhuber, Werner Poelz, Meinhard Haltmayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12766002     DOI： 10.1373/49.6.976

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  24 in total

1.  The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis.

Authors:  Otto A Sanchez; Daniel A Duprez; Lori B Daniels; Alan S Maisel; James D Otvos; Carmen A Peralta; João A Lima; Hossein Bahrami; David R Jacobs
Journal:  Metabolism       Date:  2015-04-15       Impact factor: 8.694

2.  Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  O A Sanchez; D A Duprez; H Bahrami; C A Peralta; L B Daniels; J A Lima; A Maisel; A R Folsom; D R Jacobs
Journal:  Diabetes Metab       Date:  2015-06-03       Impact factor: 6.041

3.  Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.

Authors:  T Mueller; A Gegenhuber; W Poelz; M Haltmayer
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

4.  Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.

Authors:  Ann C Long; Hollis R O'Neal; Suiwei Peng; Kirk B Lane; Richard W Light
Journal:  Chest       Date:  2010-02-05       Impact factor: 9.410

Review 5.  Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis.

Authors:  Surinder Janda; John Swiston
Journal:  BMC Pulm Med       Date:  2010-11-20       Impact factor: 3.317

6.  N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure.

Authors:  Otto Mayer; Jaroslav Simon; Markéta Plásková; Renata Cífková; Ladislav Trefil
Journal:  Eur J Epidemiol       Date:  2009-04-09       Impact factor: 8.082

7.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

8.  Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.

Authors:  Rudolf Jarai; Nelly Iordanova; Robert Jarai; Ferenc Jarai; Annamaria Raffetseder; Wolfgang Woloszczuk; Mariann Gyöngyösi; Georg Geyer; Johann Wojta; Kurt Huber
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

9.  PLASMA CONCENTRATIONS AND CORRELATIONS OF NATRIURETIC PEPTIDES AND OXYTOCIN DURING LABOR AND EARLY POSTPARTUM PERIOD.

Authors:  O F Ozer; O Kacar; O Demirci; Y S Eren; A S Bilsel
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

10.  Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.

Authors:  Jacqueline V Scott; Christine E Garnett; Manreet K Kanwar; Norman L Stockbridge; Raymond L Benza
Journal:  Am J Respir Crit Care Med       Date:  2021-03-15       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.